Genmab Announces U.S. FDA Approval of DARZALEX(TM) (daratumumab) for Multiple Myeloma and Updates Financial Guidance
Company Announcement DARZALEX (daratumumab) approved by U.S. FDA for heavily pre-treated or double refractory multiple myeloma First monoclonal antibody approved for multiple myeloma Financial guidance updated to include USD 45 million milestone payment …